Home » Topics » New compound, BioWorld Science

New compound, BioWorld Science
RSS

DPP-IV inhibition in the treatment of diabetes

Aug. 20, 1997

Spanish scientists discover anxiolytic CCKA antagonist

Aug. 18, 1997

New angiotensin II blocker from Merck KGaA

Aug. 12, 1997

Lilly reports new agent for brain injury

Aug. 11, 1997

New agent for breast cancer in development at Zenyaku Kogyo

Aug. 7, 1997

Potent calpain inhibitor discovered at Senju

July 31, 1997

Topical antiinflammatory steroids devoid of glucocorticoid-like side effects

July 31, 1997

Japanese investigators present agents for restenosis

July 31, 1997

Korean researchers describe new cephalosporins

July 31, 1997

Potential antitumor agents evaluated by Taiwan researchers

July 31, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...